Literature DB >> 7594921

Immunogenic properties of the M. leprae recombinant 18-kDa antigen purified from Saccharomyces cerevisiae; enhancement of delayed-type hypersensitivity after gamma-irradiation.

J R Pinho1, B A Cardi, H F Andrade, P J Barr, I C Bathurst, E J Vicente, A C Schenberg.   

Abstract

In this paper we report the purification and study of the immunogenic properties of the Mycobacterium leprae 18-kDa protein antigen produced and secreted by the yeast Saccharomyces cerevisiae, using an expression system we recently described [Biotech. Lett. 16 (1994) 1241-1246]. The 18-kDa protein was purified from the yeast culture media by precipitation, ion exchange chromatography (MonoQ) and exclusion size chromatography (Sephacryl S-100). The biological properties of the recombinant protein, previously irradiated with gamma rays, were assayed by immunization of mice. Humoral and cellular responses, monitored by antibody production and delayed-type hypersensitivity, respectively, were obtained. Furthermore, gamma-irradiation of the recombinant protein prior to the administration was shown to significantly potentiate the T-cell response. The data suggest that this irradiated recombinant antigen could be used in a more sensitive standardized skin test to monitor M. leprae infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594921

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  2 in total

1.  Characterization and evaluation of the enzymatic activity of tetanus toxin submitted to cobalt-60 gamma radiation.

Authors:  Giselle Pacifico Sartori; Andréa da Costa; Fernanda Lúcio Dos Santos Macarini; Douglas Oscar Ceolin Mariano; Daniel Carvalho Pimenta; Patrick Jack Spencer; Luiz Henrique da Silva Nali; Andrés Jimenez Galisteo
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-04-30

2.  Silica-based cationic bilayers as immunoadjuvants.

Authors:  Nilton Lincopan; Mariana Ra Santana; Eliana Faquim-Mauro; Maria Helena B da Costa; Ana M Carmona-Ribeiro
Journal:  BMC Biotechnol       Date:  2009-01-19       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.